Symmetry and Chirality in Topoisomerase II-DNA Crossover Recognition

By Timsit Y.   Duplantier B.   Jannink G.   Sikorav J-L.  

Journal of Molecular Biology, Vol. 284, Iss. 5, 1998-12 ,pp. : 1289-1299

Academic Press

Access to resources Recommend Favorite

Molecular basis of the targeting of topoisomerase II-mediated DNA cleavage by VP16 derivatives conjugated to triplex-forming oligonucleotides

By Duca Maria   Guianvarc'h Dominique   Oussedik Kahina   Halby Ludovic   Garbesi Anna   Dauzonne Daniel   Monneret Claude   Osheroff Neil   Giovannangeli Carine   Arimondo Paola B.  

Nucleic Acids Research, Vol. 34, Iss. 6, 2006-01 ,pp. : 1900-1911

Oxford University Press

Access to resources Recommend Favorite

Topoisomerase II inhibitors fail to induce chromosome-type aberrations in etoposide-resistant cells: evidence for essential contribution of the cleavable complex formation to the induction of chromosome-type aberrations

By Suzuki Hiroshi  

Mutagenesis, Vol. 12, Iss. 1, 1997-01 ,pp. : 29-34

Oxford University Press

Access to resources Recommend Favorite

DNA Interaction and Topoisomerase II Inhibition by the Antitumor Agent 3'-(9-Acridinylamino)-5'-hydroxymethylaniline and Derivatives

By Scarborough A.   Su T.L.   Leteutre F.F.   Pommier Y.   Chou T.C.  

Bioorganic Chemistry, Vol. 24, Iss. 3, 1996-09 ,pp. : 229-241

Academic Press

Access to resources Recommend Favorite

DNA Topoisomerase II as the Cellular Target of a Novel Antitumor Agent ICRF-193, a Bisdioxopiperazine Derivative, inXenopusEgg Extract

By Sato M.   Ishida R.   Ohsumi K.   Narita T.   Andoh T.  

Biochemical and Biophysical Research Communications, Vol. 235, Iss. 3, 1997-06 ,pp. : 571-575

Elsevier

Access to resources Recommend Favorite